Oral Self-Management of Palbociclib (Ibrance®) Using Mobile Technology
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 45
- 试验地点
- 7
- 主要终点
- Accuracy rate of medication self-administration
研究概览
简要总结
The purpose of this study is to find out whether it is feasible (acceptable to participants) to use a smartphone app to send text message reminders to take palbociclib, and whether these reminders are effective at helping people remember to take palbociclib according to the treatment schedule.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients with a breast cancer diagnosis who are initiating therapy on palbociclib (Ibrance)
- •>/= 18 years of age
- •Able to speak, read and write English
- •Willingness and ability to send and receive text messages with intervention app
- •Own a mobile telephone "smartphone" with text messaging capabilities. Only iPhone or Android operating systems support OhMD Application
- •Criteria applicable for both Control and Intervention groups
- •Flip-phones do not support OhMD Application and thus ineligible to participate
- •Initiation palbociclib (Ibrance) for the first time, either as monotherapy or in conjunction with other medication such as Lstrozole (Femara) or Fulvestrant (Faslodex)
排除标准
- •History of taking palbociclib (Ibrance)
- •Patients whose caregivers coordinate their health care
研究组 & 干预措施
Standard of Care
Participants will have a diagnosis of breast cancer and will be taking Palbociclib. Participants will receive standard of care
干预措施: Paper Drug Diary (Other)
Standard of Care + Intervention
Participants will have a diagnosis of breast cancer and will be taking Palbociclib. Participants will receive standard of care + unidirectional text messaging intervention
干预措施: OhMD APP (Other)
结局指标
主要结局
Accuracy rate of medication self-administration
时间窗: Up to 1 year
The effectiveness of a mobile technology intervention by calculating the proportion of the number of days that the participant accurately self-administers the medication divided by the number of days the medication should have been taken
次要结局
未报告次要终点